All In Biotech

Drug Trial Radar · NCT05826535

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of Rondecabtagene Autoleucel, a CD19/CD20 Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy in Participants With Aggressive B-Cell Non-Hodgkin Lymphoma

Last checked: Nov 20, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

270

Planned (sponsor's estimate)

Start

May 9, 2023

Primary completion

Dec 31, 2028

Study completion Jun 30, 2031

Sponsor

Lead sponsor
Lyell Immunopharma, Inc.Industry
Sponsor type
Industry
First posted
Apr 24, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of rondecabtagene autoleucel (ronde-cel) also known as LYL314, a dual-targeting chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma.

Conditions

  • Relapsed Non-Hodgkin Lymphoma
  • Refractory Non-Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • Large B-cell Lymphoma

Interventions

  • Rondecabtagene autoleucel (ronde-cel)Drug

    CAR T-cell therapy

  • FludarabineDrug

    Conditioning chemotherapy

  • CyclophosphamideDrug

    Conditioning chemotherapy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Phase 1: Evaluate the safety and tolerability of a single dose of ronde-cel administered as a single agentTime frame: Baseline to Month 24
  2. Phase 2: Estimate the efficacy of ronde-cel, as measured by overall response rate (ORR)Time frame: Baseline to Month 24

Locations

35 sites in 2 countries. Site status is shown where the registry gives one.

  • University of California-Irvine Medical Center

    Irvine, California · Recruiting

  • Cedars-Sinai Medical Center

    Los Angeles, California · Recruiting

  • University of California, Los Angeles (UCLA) Medical Center

    Los Angeles, California · Recruiting

  • Scripps Clinic

    San Diego, California · Recruiting

  • Colorado Blood Cancer Institute

    Denver, Colorado · Recruiting

  • Medstar Georgetown University Hospital

    Washington D.C., District of Columbia · Recruiting

  • Augusta University Medical Center

    Augusta, Georgia · Recruiting

  • Indiana Blood and Marrow Transplantation

    Indianapolis, Indiana · Recruiting

  • University of Iowa

    Iowa City, Iowa · Recruiting

  • University of Louisville Brown Cancer Center

    Louisville, Kentucky · Recruiting

  • Louisiana State University Health Sciences Center

    Shreveport, Louisiana · Recruiting

  • Corewell Health

    Grand Rapids, Michigan · Recruiting

  • University of Nebraska Medical Center

    Omaha, Nebraska · Recruiting

  • John Theurer Cancer Center Hackensack University Medical Center

    Hackensack, New Jersey · Recruiting

  • University of New Mexico Comprehensive Cancer Center

    Albuquerque, New Mexico · Recruiting

  • Roswell Park Comprehensive Cancer Center

    Buffalo, New York · Recruiting

  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center

    New York, New York · Recruiting

  • Montefiore Medical Center

    The Bronx, New York · Recruiting

  • Atrium Health Wake Forest Baptist

    Winston-Salem, North Carolina · Recruiting

  • University of Cincinnati (UC) Physicians Company, LLC

    Cincinnati, Ohio · Recruiting

  • Cleveland Clinic

    Cleveland, Ohio · Recruiting

  • Lehigh Valley Topper Cancer Center Institute

    Allentown, Pennsylvania · Recruiting

  • Thomas Jefferson University

    Philadelphia, Pennsylvania · Recruiting

  • West Penn Hospital

    Pittsburgh, Pennsylvania · Recruiting

  • Vanderbilt University Medical Center

    Nashville, Tennessee · Recruiting

  • Baylor University Medical Center

    Dallas, Texas · Recruiting

  • Texas Transplant Institute

    San Antonio, Texas · Recruiting

  • Huntsman Cancer Institute

    Salt Lake City, Utah · Recruiting

  • Intermountain Healthcare

    Salt Lake City, Utah · Recruiting

  • Virginia Oncology Associates

    Norfolk, Virginia · Recruiting

  • Virginia Commonwealth University-Massey Cancer Center

    Richmond, Virginia · Recruiting

  • Medical College of Wisconsin

    Milwaukee, Wisconsin · Recruiting

  • The Alfred Hospital

    Melbourne, Australia · Recruiting

  • Sir Charles Gairdner Hospital

    Nedlands, Western Australia, Australia · Recruiting

  • Royal Perth Hospital

    Perth, Western Australia, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.